1. Home
  2. RENB

RENB

Renovaro Biosciences Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.

Founded: 2011 Country:
United States
United States
Employees: N/A City: SUITE 906 LOS ANGELES
Market Cap: 311.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 311.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.70 EPS Growth: N/A
52 Week Low/High: $0.39 - $5.25 Next Earning Date: 05-10-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: